Bovilis® BVD Suspension for injection for cattle
An inactivated BVD vaccine for cows and heifers to protect the foetus against transplacental infection with bovine viral diarrhoea virus (BVDV). Can be mixed and administered with Bovilis IBR Marker Live; see Bovilis IBR Marker Live datasheet for more information.
Presentation
Suspension for injection
Active ingredients
Each dose of 2 ml contains: Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86, containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*
*Mean virus neutralizing titre obtained in the potency test
Target species
Cattle (cows and heifers).
Indications for use
For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with BVDV.
Safety and efficacy data are available which demonstrate that for re-vaccination in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR Marker Live) - this vaccine can be mixed and administered with Bovilis IBR Marker Live.
Withdrawal periods
Cattle - milk 0 hours, meat and offal 0 days
Packaging
Vials of glass (hydrolytic type I, Ph. Eur.) or plastic (polyethylene-terephthalate, PET) closed with a rubber (halogenobutyl) stopper and an aluminium cap.
Pack sizes:
Cardboard box containing 1 glass or plastic vial of 2 ml (1 dose)
Cardboard box containing 1 glass or plastic vial of 10 ml (5 doses)
Cardboard box containing 1 glass or plastic vial of 20 ml (10 doses)
Cardboard box containing 1 glass or plastic vial of 50 ml (25 doses)
Cardboard box containing 1 glass or plastic vial of 100 ml (50 doses)
Cardboard box containing 1 glass or plastic vial of 250 ml (125 doses)
Not all pack sizes may be marketed.
Legal category
POM-V
Bovilis® IBR Marker Live, Lyophilisate and Solvent for Suspension for Cattle, contains live Bovine Herpesvirus, POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: January 2026
